LinkedIn Profile

Access Solid Biosciences historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
nasdaq:sldb 5368403 Apr 28th, 2024 12:00AM Solid Biosciences 8.1K 114.00 Open Apr 28th, 2024 12:00AM Apr 28th, 2024 12:00AM Solid Biosciences is a life science company focused on advancing a portfolio of neuromuscular and cardiac programs for the treatment of devastating diseases, including Duchenne, Friedreich’s ataxia, BAG3 mediated dilated cardiomyopathy, and additional cardiac diseases. We aim to be the center of excellence across the entire disease spectrum, serving as a catalyst to bring together those with the expertise in science, technology, disease management and care. Disease-focused and founded by a family directly impacted, our mandate is simple yet comprehensive - attack the roots of the disease and improve daily life for patients. Solid is headquartered in Charlestown, MA, USA. Open Duchenne muscular dystrophy, Biotechnology, and Biotechnology research Open 500 Rutherford Ave Boston Massachusetts US 02129 Solid Biosciences
nasdaq:sldb 5368403 Apr 27th, 2024 12:00AM Solid Biosciences 8.1K 114.00 Open Apr 26th, 2024 11:39PM Apr 26th, 2024 11:39PM Solid Biosciences is a life science company focused on advancing a portfolio of neuromuscular and cardiac programs for the treatment of devastating diseases, including Duchenne, Friedreich’s ataxia, BAG3 mediated dilated cardiomyopathy, and additional cardiac diseases. We aim to be the center of excellence across the entire disease spectrum, serving as a catalyst to bring together those with the expertise in science, technology, disease management and care. Disease-focused and founded by a family directly impacted, our mandate is simple yet comprehensive - attack the roots of the disease and improve daily life for patients. Solid is headquartered in Charlestown, MA, USA. Open Duchenne muscular dystrophy, Biotechnology, and Biotechnology research Open 500 Rutherford Ave Boston Massachusetts US 02129 Solid Biosciences
nasdaq:sldb 5368403 Apr 26th, 2024 12:00AM Solid Biosciences 8.1K 114.00 Open Apr 25th, 2024 11:47PM Apr 26th, 2024 09:08AM Solid Biosciences is a life science company focused on advancing a portfolio of neuromuscular and cardiac programs for the treatment of devastating diseases, including Duchenne, Friedreich’s ataxia, BAG3 mediated dilated cardiomyopathy, and additional cardiac diseases. We aim to be the center of excellence across the entire disease spectrum, serving as a catalyst to bring together those with the expertise in science, technology, disease management and care. Disease-focused and founded by a family directly impacted, our mandate is simple yet comprehensive - attack the roots of the disease and improve daily life for patients. Solid is headquartered in Charlestown, MA, USA. Open Duchenne muscular dystrophy, Biotechnology, and Biotechnology research Open 500 Rutherford Ave Boston Massachusetts US 02129 Solid Biosciences
nasdaq:sldb 5368403 Apr 25th, 2024 12:00AM Solid Biosciences 8.1K 113.00 Open Apr 24th, 2024 11:41PM Apr 25th, 2024 07:20PM Solid Biosciences is a life science company focused on advancing a portfolio of neuromuscular and cardiac programs for the treatment of devastating diseases, including Duchenne, Friedreich’s ataxia, BAG3 mediated dilated cardiomyopathy, and additional cardiac diseases. We aim to be the center of excellence across the entire disease spectrum, serving as a catalyst to bring together those with the expertise in science, technology, disease management and care. Disease-focused and founded by a family directly impacted, our mandate is simple yet comprehensive - attack the roots of the disease and improve daily life for patients. Solid is headquartered in Charlestown, MA, USA. Open Duchenne muscular dystrophy, Biotechnology, and Biotechnology research Open 500 Rutherford Ave Boston Massachusetts US 02129 Solid Biosciences
nasdaq:sldb 5368403 Apr 24th, 2024 12:00AM Solid Biosciences 8.1K 113.00 Open Apr 23rd, 2024 11:49PM Apr 24th, 2024 11:49AM Solid Biosciences is a life science company focused on advancing a portfolio of neuromuscular and cardiac programs for the treatment of devastating diseases, including Duchenne, Friedreich’s ataxia, BAG3 mediated dilated cardiomyopathy, and additional cardiac diseases. We aim to be the center of excellence across the entire disease spectrum, serving as a catalyst to bring together those with the expertise in science, technology, disease management and care. Disease-focused and founded by a family directly impacted, our mandate is simple yet comprehensive - attack the roots of the disease and improve daily life for patients. Solid is headquartered in Charlestown, MA, USA. Open Duchenne muscular dystrophy, Biotechnology, and Biotechnology research Open 500 Rutherford Ave Boston Massachusetts US 02129 Solid Biosciences
nasdaq:sldb 5368403 Apr 23rd, 2024 12:00AM Solid Biosciences 8.1K 113.00 Open Apr 22nd, 2024 11:31PM Apr 22nd, 2024 11:31PM Solid Biosciences is a life science company focused on advancing a portfolio of neuromuscular and cardiac programs for the treatment of devastating diseases, including Duchenne, Friedreich’s ataxia, BAG3 mediated dilated cardiomyopathy, and additional cardiac diseases. We aim to be the center of excellence across the entire disease spectrum, serving as a catalyst to bring together those with the expertise in science, technology, disease management and care. Disease-focused and founded by a family directly impacted, our mandate is simple yet comprehensive - attack the roots of the disease and improve daily life for patients. Solid is headquartered in Charlestown, MA, USA. Open Duchenne muscular dystrophy, Biotechnology, and Biotechnology research Open 500 Rutherford Ave Boston Massachusetts US 02129 Solid Biosciences
nasdaq:sldb 5368403 Apr 22nd, 2024 12:00AM Solid Biosciences 8.1K 113.00 Open Apr 22nd, 2024 12:16AM Apr 22nd, 2024 12:16AM Solid Biosciences is a life science company focused on advancing a portfolio of neuromuscular and cardiac programs for the treatment of devastating diseases, including Duchenne, Friedreich’s ataxia, BAG3 mediated dilated cardiomyopathy, and additional cardiac diseases. We aim to be the center of excellence across the entire disease spectrum, serving as a catalyst to bring together those with the expertise in science, technology, disease management and care. Disease-focused and founded by a family directly impacted, our mandate is simple yet comprehensive - attack the roots of the disease and improve daily life for patients. Solid is headquartered in Charlestown, MA, USA. Open Duchenne muscular dystrophy, Biotechnology, and Biotechnology research Open 500 Rutherford Ave Boston Massachusetts US 02129 Solid Biosciences
nasdaq:sldb 5368403 Apr 21st, 2024 12:00AM Solid Biosciences 8.1K 113.00 Open Apr 21st, 2024 03:16AM Apr 21st, 2024 03:16AM Solid Biosciences is a life science company focused on advancing a portfolio of neuromuscular and cardiac programs for the treatment of devastating diseases, including Duchenne, Friedreich’s ataxia, BAG3 mediated dilated cardiomyopathy, and additional cardiac diseases. We aim to be the center of excellence across the entire disease spectrum, serving as a catalyst to bring together those with the expertise in science, technology, disease management and care. Disease-focused and founded by a family directly impacted, our mandate is simple yet comprehensive - attack the roots of the disease and improve daily life for patients. Solid is headquartered in Charlestown, MA, USA. Open Duchenne muscular dystrophy, Biotechnology, and Biotechnology research Open 500 Rutherford Ave Boston Massachusetts US 02129 Solid Biosciences
nasdaq:sldb 5368403 Apr 20th, 2024 12:00AM Solid Biosciences 8.1K 113.00 Open Apr 20th, 2024 12:04AM Apr 20th, 2024 05:39PM Solid Biosciences is a life science company focused on advancing a portfolio of neuromuscular and cardiac programs for the treatment of devastating diseases, including Duchenne, Friedreich’s ataxia, BAG3 mediated dilated cardiomyopathy, and additional cardiac diseases. We aim to be the center of excellence across the entire disease spectrum, serving as a catalyst to bring together those with the expertise in science, technology, disease management and care. Disease-focused and founded by a family directly impacted, our mandate is simple yet comprehensive - attack the roots of the disease and improve daily life for patients. Solid is headquartered in Charlestown, MA, USA. Open Duchenne muscular dystrophy, Biotechnology, and Biotechnology research Open 500 Rutherford Ave Boston Massachusetts US 02129 Solid Biosciences
nasdaq:sldb 5368403 Apr 19th, 2024 12:00AM Solid Biosciences 8.1K 113.00 Open Apr 19th, 2024 04:39AM Apr 19th, 2024 04:39AM Solid Biosciences is a life science company focused on advancing a portfolio of neuromuscular and cardiac programs for the treatment of devastating diseases, including Duchenne, Friedreich’s ataxia, BAG3 mediated dilated cardiomyopathy, and additional cardiac diseases. We aim to be the center of excellence across the entire disease spectrum, serving as a catalyst to bring together those with the expertise in science, technology, disease management and care. Disease-focused and founded by a family directly impacted, our mandate is simple yet comprehensive - attack the roots of the disease and improve daily life for patients. Solid is headquartered in Charlestown, MA, USA. Open Duchenne muscular dystrophy, Biotechnology, and Biotechnology research Open 500 Rutherford Ave Boston Massachusetts US 02129 Solid Biosciences

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.